Dr Vinod Balasubramaniam, Senior Lecturer and and Co-Lead, Infection and Immunity Research Strength from the Jeffrey Cheah School of Medicine & Health Sciences , shares with us the efficacy of mixing vaccines but also raises concerns on the rise of sporadic cases, the lack of testing and the reality of us moving out from Phase 1

Image Credit: Rawpixel.com | Shutterstock.com

Produced by: Arleen Webber

Presented by: Wong Shou Ning, Philip See, Shazana Mokhtar

This and more than 60,000 other podcasts in your hand. Download the all new BFM mobile app.

Categories:  Politics,  Social Issues,  law & legal matters,  Personal Finance,  Investments,  Financial Literacy,  Young Finance,  Personal Development,  Entrpreneurship,  SME,  Education,  Tech,  Health Policy,  Diseases & Conditions,  Mental Health,  Healthy Living,  Fitness,  Medical Innovation and Technology,  Science

Tags:  covid-19,  vaccine,  pandemic,  immunisation,  herd immunity,  vaccine mixing,  Astrazeneca,  Pfizer,